HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer

Herceptin (trastuzumab) is used in patients with breast cancer who have HER2 (ErbB2)–positive tumours. However, its mechanisms of action and how acquired resistance to Herceptin occurs are still poorly understood. It was previously thought that the anti-HER2 monoclonal antibody Herceptin inhibits HE...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Gijsen, Merel, King, Peter, Perera, Tim, Parker, Peter J., Harris, Adrian L., Larijani, Banafshé, Kong, Anthony
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2010
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3006345/
https://ncbi.nlm.nih.gov/pubmed/21203579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pbio.1000563
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares